Related Experiment Video

Updated: Feb 10, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

946

An oncogenic kinase: putting PAK5 forward

Yi-Yang Wen1, Jun-Nian Zheng, Dong-Sheng Pei

  • 1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College , 84 West Huai-hai Road, Xuzhou, Jiangsu , China +86 0516 85582513 ; dspei@xzmc.edu.cn ; jnzheng@xzmc.edu.cn.

Expert Opinion on Therapeutic Targets
|May 30, 2014
PubMed
Abstract

Insights

p21-activated kinase 5 (PAK5) is overexpressed in many tumors, contributing to proliferation and anti-apoptosis. Understanding PAK5

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • p21-activated kinase 5 (PAK5) overexpression is implicated in various cancers.
  • PAK5 plays a role in cellular processes crucial for tumor growth, including proliferation, cytoskeleton regulation, and anti-apoptosis.

Purpose of the Study:

  • To review the current understanding of PAK5's function as an oncogenic kinase.
  • To elucidate the mechanisms and pathways by which PAK5 regulates tumor cellular processes.

Main Methods:

  • This review synthesizes existing research on PAK5.
  • It discusses molecular pathways involved in PAK5-mediated cytoskeleton regulation, anti-apoptosis, and proliferation.

Main Results:

  • PAK5, a serine/threonine kinase, shares domains with other PAKs but has unique regions.
  • Its overexpression in tumors is linked to enhanced proliferation, altered cytoskeleton, and resistance to apoptosis.
  • PAK5 exhibits regulatory mechanisms independent of Rho GTPases.

Conclusions:

  • PAK5 acts as a distinct signaling molecule in tumor progression.
  • Its unique properties suggest potential as a therapeutic target.
  • Further research into PAK5's independent regulatory mechanisms is warranted for novel cancer treatments.
Keywords:
antiapoptosisinvasionmetastasisp21-activated kinase 5proliferation

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.7K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

No description available
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
553